Tag: Alucent Biomedical

natural

Alucent Biomedical announces US$35 million Series B financing

Alucent Biomedical recently announced the close of a US$35 million Series B financing round led by a large multinational strategic investor and joined by...
natural

Alucent Biomedical announces FDA approval to proceed with natural vascular scaffolding...

Alucent Biomedical has received US Food and Drug Administration (FDA) approval to proceed with a phase 1 clinical trial to evaluate the safety and...